Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments OXFORD, UK — ProImmune, Ltd., a global leader in immunological reagents and services, today announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a high-containment, infectious disease research facility, to develop innovative tools […]
Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications Bio-Rad anti-idiotypic antibodies HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today extended its range of recombinant monoclonal anti-idiotypic antibodies, with the introduction of eight antibodies specific to romosuzumab […]
CAMBRIDGE, England — Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, today announced SimpleStep Ignite™ ELISA, a next generation chemiluminescent immunoassay platform designed for scientists who need faster and higher quality decisions without compromising data integrity. Delivering results in 55 minutes – up to 6× faster than traditional colorimetric ELISAs, SimpleStep Ignite™ combines 50× greater sensitivity with an up to 35× […]
WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K study, one of the region’s most ambitious and diverse population-scale biobank initiatives. The collaboration reflects growing investments from national population studies looking to harness proteomics […]
CTL adds analyzers, software, consumables, and services at a workflow-critical measurement layer across translational and clinical research SHAKER HEIGHTS, Ohio — VION Biosciences (“VION”), a life sciences company building differentiated capabilities across research, diagnostics, and drug development workflows, today announced the closing of its acquisition of Cellular Technology Limited (“CTL”), a provider of functional immune […]
David P. King nominated to support next phase of growth and innovation; Frances Arnold, Robert S. Epstein, and Gary S. Guthart to retire from the Board SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced changes to its Board of Directors. Frances Arnold, PhD, Robert S. Epstein, MD, and Gary S. Guthart, PhD, will retire from the Board in connection with the company’s upcoming […]
RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Executive Vice President and Chief Financial Officer (CFO), R. Brent Jones, will leave the Company on or before June 24, 2026. Avantor has initiated a search to […]
BILLERICA, Mass. — Bruker Corporation (Nasdaq: BRKR) announces the appointment of Mr. Thierry L. Bernard to serve on its Board of Directors, effective as of today. Mr. Bernard is an international life-science tools and diagnostics industry executive with decades of relevant leadership, strategic and operational experience. Thierry Bernard Frank H. Laukien, the Chairman, President and CEO […]
COLUMBIA, Md. — Shimadzu Scientific Instruments Inc., a Shimadzu Group company, has officially opened its new research and development (R&D) facility in South San Francisco, California. Since April 2024, SSI has been enhancing its R&D division with a focus on developing analytical instruments, software, applications and lab automation solutions tailored to the needs of pharmaceutical […]
Enables expression of active GPCRs in 48 hours Panel supports screening to scale-up on eProtein Discovery Cambridge, UK, and Boston MA, USA: Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its nanodisc panel to support screening and scale-up of G-Protein Coupled Receptors (GPCRs). Building on the eProtein Discovery™ membrane […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
